Multi-Centre, Open-Label, Two Segment, Parallel Group Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise

NCT00745264 Phase 1 COMPLETED

* Comparison of the plasma PK after single use of 100 mg ketoprofen from Diractin®. 50 mg applied on 2 major joints to * 400 mg ketoprofen from Diractin® (100 mg applied to 4 joints - overexposure) * 100 mg and 400 mg ketoprofen from Diractin® used concomitant with heat application * 100 mg and 400 mg ketoprofen from Diractin® used concomitant with moderate exercise

Details

Lead sponsor	IDEA AG
Phase	Phase 1
Status	COMPLETED
Enrolment	80
Start date	2007-10
Completion	2008-05

Conditions

• Pharmacokinetic

Interventions

• Diractin
• Diractin
• Diractin
• Diractin

Countries

Germany